Adaptimmune Therapeutics PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Abingdon, Oxfordshire
SEC filing record 1 source field available
Fiscal year end
31 December
Adaptimmune Therapeutics PLC has filed 808 SEC EDGAR filings since 02 Oct 2014

SEC filing history

Showing 1-25 of 808 matching filings.

Per page
25
Current page
1
RW File 333-286639

RW

Filing date
22 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88833

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-286639

EFFECT filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88833

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-233560

424B3 filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 001-37368

15-12G

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-275813

S-8 POS

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-233558

S-8 POS

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-203929

S-8 POS

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-286639

POS AM

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-37368

FORM 25

Filing date
28 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
08 Oct 2025
Reporting date
10 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37368

144 filing

Filing date
02 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Aug 2025
Reporting date
28 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37368

144 filing

Filing date
29 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Aug 2025
Reporting date
15 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88833

SCHEDULE 13D/A filing

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88833

SCHEDULE 13G/A filing

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .